Asendatud 4-amino-tiasool-2-üüli ühendid kui tsükliinisõltuvusega kinaaside inhibiitorid

Pharmaceutical compositions containing effective amounts of CDK-inhibiting diaminothiazole compounds of the following formula (where R1 and R2 are as defined in the specification) or their salts, or prodrugs or active metabolites of such compounds or salts, are useful for treating disorders and dise...

Full description

Saved in:
Bibliographic Details
Main Authors YI YANG, ROHIT K. DUVADIE, LIN LI, WESLEY K. M. CHONG, WEI XIAO, SHAO SONG CHU
Format Patent
LanguageEstonian
Published 15.06.2001
Edition7
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Pharmaceutical compositions containing effective amounts of CDK-inhibiting diaminothiazole compounds of the following formula (where R1 and R2 are as defined in the specification) or their salts, or prodrugs or active metabolites of such compounds or salts, are useful for treating disorders and diseases such as cancer:In preferred embodiments, R1 and R2 are independently unsubstituted or substituted carbocyclic or heterocyclic aryl ring structures. Compounds where R2 is ortho-substituted aryl are especially potent inhibitors of CDKs such as CDK4.
AbstractList Pharmaceutical compositions containing effective amounts of CDK-inhibiting diaminothiazole compounds of the following formula (where R1 and R2 are as defined in the specification) or their salts, or prodrugs or active metabolites of such compounds or salts, are useful for treating disorders and diseases such as cancer:In preferred embodiments, R1 and R2 are independently unsubstituted or substituted carbocyclic or heterocyclic aryl ring structures. Compounds where R2 is ortho-substituted aryl are especially potent inhibitors of CDKs such as CDK4.
Author ROHIT K. DUVADIE
LIN LI
WEI XIAO
WESLEY K. M. CHONG
SHAO SONG CHU
YI YANG
Author_xml – fullname: YI YANG
– fullname: ROHIT K. DUVADIE
– fullname: LIN LI
– fullname: WESLEY K. M. CHONG
– fullname: WEI XIAO
– fullname: SHAO SONG CHU
BookMark eNqNyrsNwjAURmEXUPDawQxgCQUKKCMUxAC0CF3whfyKsSOuzWZ07rwYIDEApznNN1YDHzyP1LEW9pZisnpl6A4fTARJCM5UpuSSHXTJ7cfA6i5BRym5c4CHlJeL6ZmEb6Q7eCKBZQ3f4gzE8ICdquGVnPDs94ma75rDdm-4DyeWni7sOZ6aplp8q9abevmPeQM3-UG_
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Edition 7
ExternalDocumentID EE200000289A
GroupedDBID EVB
ID FETCH-epo_espacenet_EE200000289A3
IEDL.DBID EVB
IngestDate Fri Jul 19 13:13:53 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Estonian
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EE200000289A3
Notes Application Number: EEP200000289
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20010615&DB=EPODOC&CC=EE&NR=200000289A
ParticipantIDs epo_espacenet_EE200000289A
PublicationCentury 2000
PublicationDate 20010615
PublicationDateYYYYMMDD 2001-06-15
PublicationDate_xml – month: 06
  year: 2001
  text: 20010615
  day: 15
PublicationDecade 2000
PublicationYear 2001
RelatedCompanies AGOURON PHARMACEUTICALS, INC
RelatedCompanies_xml – name: AGOURON PHARMACEUTICALS, INC
Score 2.540385
Snippet Pharmaceutical compositions containing effective amounts of CDK-inhibiting diaminothiazole compounds of the following formula (where R1 and R2 are as defined...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Asendatud 4-amino-tiasool-2-üüli ühendid kui tsükliinisõltuvusega kinaaside inhibiitorid
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20010615&DB=EPODOC&locale=&CC=EE&NR=200000289A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFPVNp6Lzgwqyt2Dt0tU-DNnajiHsA5myFxlN27m42g6b6l_mW9_6j3mpm_qibyEJITn45e5yd78AXJia56KlyhDfpooOiq8TZlCT6Co2NU9DG0VGdHv9Rvee3o71cQmeV7UwBU_oe0GOiIjyEO-iuK8XP49YdpFbmVwyjl3xTWfUtGsr71g6OHrNbjed4cAeWDXLaqLL1L8rKqiLqFprDdZxc4ZM_3Ie2rIqZfFbpXR2YGOIq0ViF0qBqMCWtfp5rQKbvWXAG5tL7CV78NiSr8CuSH2FEveFRzFBdCZxHBKN5FmehVzJsxnO4b4yT7kikjybh1xyh-QfoUjf0iR4cpU5j1xXftKp8GjGGeeSJsTfh_OOM7K6BPc5-RbKxHF-jlQ_gHIUR8EhKIFaN1WzPvUMymhg-KZkTJ8y07-mVFc9dgTVv9ep_jd4DNtf-VcNcqWfQFm8psEpKmTBzgpJfgLhf5N3
link.rule.ids 230,309,783,888,25578,76884
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT8IwFH9BNOJNUaP4NRPDrXGODdiBGNhGUPmKQcPFkHUbUpkbcZ3-Zd647R_zdYJ40VvTNk37kl_fV9-vABe64thoqVLEty6jg-JqhFZUnWgyNhVHQRtFZHQ73XLrQb0dasMMvCxrYVKe0I-UHBER5SDeeXpfz1ZBLDN9WxldUoZd4XVzUDOLS-9YODha0WzUrH7P7BlFw6ihy9S9Tyuo06xafQ3W0cSuCp5967EhqlJmv1VKcxs2-rhawHcg4_E85Izlz2t52OwsEt7YXGAv2oWnuogC2zx2JZXYrywICaIzCkOfKCSZJ3OfScl8gnOYK01jJvEomU99JrhDkk-fx-9x5D3b0pQFti0-6ZRYMGGUMUET4u7BedMaGC2C-xz9CGVkWasjlfYhG4SBdwCSJ5d0WS-NnYpKVa_i6oIxfUx1t6qqmuzQQyj8vU7hv8EzyLUGnfaofdO9O4Kt77dYZXKlHUOWv8XeCSpnTk9TqX4B9JqWZw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Asendatud+4-amino-tiasool-2-%C3%BC%C3%BCli+%C3%BChendid+kui+ts%C3%BCkliinis%C3%B5ltuvusega+kinaaside+inhibiitorid&rft.inventor=YI+YANG&rft.inventor=ROHIT+K.+DUVADIE&rft.inventor=LIN+LI&rft.inventor=WESLEY+K.+M.+CHONG&rft.inventor=WEI+XIAO&rft.inventor=SHAO+SONG+CHU&rft.date=2001-06-15&rft.externalDBID=A&rft.externalDocID=EE200000289A